| Issue Date | Title | Author(s) |
| Mar-2012 | Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca; Baran, Yusuf |
| Dec-2019 | Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cells | Uzuner, Erez |
| Jul-2016 | Molecular mechanisms of drug resistance and its reversal in cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
| Jan-2013 | Novel agents targeting bioactive sphingolipids for the treatment of cancer | Adan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf |
| Nov-2011 | A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes | Gencer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| Oct-2011 | The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells | Güçlüler, Gözde; Pişkin, Özden; Baran, Yusuf |
| Feb-2011 | The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells | Çakır, Zeynep; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| Aug-2011 | Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
